Rapid Micro Biosystems (RPID) Other Non-Current Assets (2020 - 2026)
Rapid Micro Biosystems' (RPID) quarterly Other Non-Current Assets came in at $245000.0 in Q1 2026, down 32.88% year-on-year from $365000.0 in Q1 2025, and down 13.73% quarter-over-quarter from $284000.0 in Q4 2025.
Rapid Micro Biosystems (RPID) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems has disclosed Other Non-Current Assets across 7 years of filings, most recently posting $245000.0 for Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $245000.0, down 32.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $245000.0 (down 32.88% YoY), and the FY2025 annual result was $284000.0, down 46.52% from the prior year.
- Other Non-Current Assets came in at $245000.0 for Q1 2026 at Rapid Micro Biosystems, down from $284000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1.5 million in Q1 2022 to a low of $211000.0 in Q3 2025.
- The 5-year median for Other Non-Current Assets is $300000.0 (2022), against an average of $611294.1.
- Across the five-year window, Other Non-Current Assets surged 362.32% in 2022 and plunged 73.11% in 2024, its largest moves.
- Rapid Micro Biosystems' Other Non-Current Assets stood at $300000.0 in 2022, then slipped by 5.33% to $284000.0 in 2023, then soared by 86.97% to $531000.0 in 2024, then sank by 46.52% to $284000.0 in 2025, then slipped by 13.73% to $245000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $245000.0 (Q1 2026), $284000.0 (Q4 2025), and $211000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 828.89 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 211.40 Mn |
| 10 | Rapid Micro Biosystems | 77.24 Mn | 54.29 Mn | 371,000.00 | 245,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 245,000.00 |
| Dec 31, 2025 | 284,000.00 |
| Sep 30, 2025 | 211,000.00 |
| Jun 30, 2025 | 284,000.00 |
| Mar 31, 2025 | 365,000.00 |
| Dec 31, 2024 | 531,000.00 |
| Sep 30, 2024 | 284,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 284,000.00 |
| Dec 31, 2023 | 284,000.00 |
| Sep 30, 2023 | 856,000.00 |
| Jun 30, 2023 | 956,000.00 |
| Mar 31, 2023 | 1.06 Mn |
| Dec 31, 2022 | 300,000.00 |
| Sep 30, 2022 | 1.31 Mn |
| Jun 30, 2022 | 1.38 Mn |
| Mar 31, 2022 | 1.46 Mn |
| Dec 31, 2021 | 300,000.00 |
| Sep 30, 2021 | 284,000.00 |
| Jun 30, 2021 | 2.64 Mn |